Home › Funds › D. E. Shaw & Co › LAB
D. E. Shaw & Co position in LAB
STANDARD BIOTOOLS INC · Industrials
Latest position (Q2 2026)2.82M sh
Reported value held$2.32M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 789.21K | $5.20M | New |
| Q4 2021 | 891.63K | $3.50M | Add |
| Q1 2022 | 830.03K | $2.98M | Reduce |
| Q2 2022 | 889.04K | $1.42M | Add |
| Q3 2022 | 807.15K | $888.00K | Reduce |
| Q4 2022 | 787.21K | $921.04K | Reduce |
| Q1 2023 | 580.50K | $1.13M | Reduce |
| Q2 2023 | 343.70K | $663.34K | Reduce |
| Q3 2023 | 144.60K | $419.33K | Reduce |
| Q1 2026 | 199.08K | $183.02K | New |
| Q2 2026 | 2.82M | $2.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- Viking Global Investors 58.65M sh · $48.25M · Q2 2026
- Vanguard Group 17.30M sh · $22.14M · Q4 2025
- BlackRock Inc 8.25M sh · $6.79M · Q2 2026
- Royce & Associates 4.53M sh · $3.72M · Q2 2026
- Geode Capital Management 3.90M sh · $3.21M · Q2 2026
- Millennium Management 3.51M sh · $2.89M · Q2 2026
- Morgan Stanley 2.83M sh · $2.33M · Q2 2026
- Citadel Advisors 2.38M sh · $1.96M · Q2 2026
- Arrowstreet Capital 1.99M sh · $1.64M · Q2 2026
- Charles Schwab Investment Management 1.76M sh · $1.45M · Q2 2026